000 | 03286nam a22004693i 4500 | ||
---|---|---|---|
001 | EBC5338785 | ||
003 | MiAaPQ | ||
005 | 20240724113108.0 | ||
006 | m o d | | ||
007 | cr cnu|||||||| | ||
008 | 240724s2012 xx o ||||0 eng d | ||
020 |
_a9789838616553 _q(electronic bk.) |
||
020 | _z9789838615648 | ||
035 | _a(MiAaPQ)EBC5338785 | ||
035 | _a(Au-PeEL)EBL5338785 | ||
035 | _a(CaPaEBR)ebr11540309 | ||
035 | _a(OCoLC)1031343886 | ||
040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
050 | 4 | _aHD9665.5 .I473 2012 | |
082 | 0 | _a615.10688 | |
100 | 1 | _aImran, Masood. | |
245 | 1 | 0 |
_aDoctors and Pharmaceutical Industry : _bInsight from Malaysian Scenario. |
250 | _a1st ed. | ||
264 | 1 |
_aGelugor : _bPenerbit USM, _c2012. |
|
264 | 4 | _c©2012. | |
300 | _a1 online resource (51 pages) | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
505 | 0 | _aCover -- Half Title Page -- Title Page -- Copyright Page -- Contents -- List of Tables and Figures -- Preface -- Acknowledgements -- List of Abbreviations -- 1: Introduction -- 1.1: Data collection procedure -- 1.2: Data management and analysis -- 1.3: Ethical requirements -- 2: Findings -- 2.1: Survey response and characteristics of GPs -- 2.2: Sources of drug information used by Malaysian GPs -- 2.3: GPs' opinions about the importance of MPs working in Malaysia -- 2.4: GPs' experiences about the knowledge of MPs -- 2.5: GPs' opinion about the minimum qualifications needed to appoint a MP -- 2.6: GPs' opinion about the problems they may face without MPs -- 2.7: Frequency of GPs received drug samples from representatives, and their usual quantity and use -- 2.8: Common practice-related gifts received by practitioners -- 2.9: Exclusive gifts received by GPs -- 2.10: Greetings and gifts received on personal and general special occasions -- 2.11: Prescription-based incentive offers received by GPs from pharmaceutical companies -- 2.12: The involvement of pharmaceutical industry in organizing and sponsoring educational events for healthcare professionals -- 2.13: Awareness among GPs about the existing codes of conduct, regulations and guidelines in interacting with pharmaceutical companies -- 3: Discussion -- 4: Conclusions -- References -- Appendix 1: The Instrument -- Appendix 2: Letter of Approval for Research Ethics -- List of Authors -- Index -- Back Cover. | |
588 | _aDescription based on publisher supplied metadata and other sources. | ||
590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
650 | 0 | _aDrugs-Marketing. | |
650 | 0 | _aPharmaceutical industry-Malaysia. | |
650 | 0 | _aPharmaceutical services-Malaysia. | |
655 | 4 | _aElectronic books. | |
700 | 1 | _aMohamed Azmi, Ahmad Hassali. | |
700 | 1 | _aMohamed Izham, Mohamed Ibrahim. | |
776 | 0 | 8 |
_iPrint version: _aImran, Masood _tDoctors and Pharmaceutical Industry: Insight from Malaysian Scenario _dGelugor : Penerbit USM,c2012 _z9789838615648 |
797 | 2 | _aProQuest (Firm) | |
856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5338785 _zClick to View |
999 |
_c802 _d802 |